Clinical trial
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
NCT02315729 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 30, 2016
- Completion date
- December 31, 2028
- Enrollment
- 380 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adolescent idiopathic scoliosis